Our study may provide the novel approach to suppress FOXO3 by targeting 67LR because several leukemias, including chronic myeloid leukaemia exhibit significantly upregulated 67LR expression23, 47. Here, FOXO3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.